Cynthia L. Lucchese

Insider Reports History

Reporting-owner location: Indianapolis, IN
Latest reporting-owner signature: /s/ Chase Leavitt, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Cynthia L. Lucchese

Form 4 holding Director

COOPER COMPANIES, INC.

Security class: Common Stock
Shares / value: 12,767
Estimated value: $793,946
Report date: 01 Apr 2026
Price: $84.06
Ownership: Direct

Form 4 holding Director

COOPER COMPANIES, INC.

Security class: Restricted Stock Units
Shares / value: 3,779
Estimated value: $269,979
Report date: 01 Apr 2026
Price: $81.27
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Inari Medical, Inc.

Security class: Common Stock
Shares / value: 0
Estimated value: $0
Report date: 19 Feb 2025
Price: $0.4569
Ownership: Direct

Form 4 holding Director

Mobia Medical, Inc.

Security class: Common Stock
Shares / value: 125,000
Estimated value
Report date: 11 May 2026
Price
Ownership: Direct

Form 4 holding Director

Mobia Medical, Inc.

Security class: Stock Option
Shares / value: 31,520
Estimated value
Report date: 07 May 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

HANGER, INC.

Security class: Common Stock
Shares / value: 0
Estimated value
Report date: 03 Oct 2022
Price: $18.75
Ownership: Direct

Form 4 holding Director

Inari Medical, Inc.

Security class: Stock Option
Shares / value: 0
Estimated value
Report date: 19 Feb 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Intersect ENT, Inc.

Security class: Common Stock
Shares / value: 0
Estimated value
Report date: 13 May 2022
Price: $28.25
Ownership: Direct

Form 4 holding Director

Intersect ENT, Inc.

Security class: Stock Options (Right to buy)
Shares / value: 0
Estimated value
Report date: 13 May 2022
Price: $28.25
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Cynthia L. Lucchese

4 MOBI

Mobia Medical, Inc.

Report period: 07 May 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 11 May 2026, 21:36
Role: Director
Next action: Open filing details

3 MOBI

Mobia Medical, Inc.

Report period: 07 May 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 07 May 2026, 17:31
Role: Director
Next action: Open filing details

4 COO

COOPER COMPANIES, INC.

Report period: 01 Apr 2026
Transactions: 3
Transaction value: $0
Accepted by SEC: 06 Apr 2026, 17:14
Role: Director
Next action: Open filing details

4 COO

COOPER COMPANIES, INC.

Report period: 22 Dec 2025
Transactions: 1
Transaction value: +$149,963
Accepted by SEC: 23 Dec 2025, 16:08
Role: Director
Next action: Open filing details

4 COO

COOPER COMPANIES, INC.

Report period: 01 Apr 2025
Transactions: 3
Transaction value: $0
Accepted by SEC: 03 Apr 2025, 16:07
Role: Director
Next action: Open filing details

4

Inari Medical, Inc.

Report period: 19 Feb 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 19 Feb 2025, 20:04
Role: Director
Next action: Open filing details

4/A

Inari Medical, Inc.

Report period: 24 Apr 2024
Transactions: 1
Transaction value: +$174,984
Accepted by SEC: 31 May 2024, 16:44
Role: Director
Next action: Open filing details

4

Inari Medical, Inc.

Report period: 24 Apr 2024
Transactions: 1
Transaction value: +$174,984
Accepted by SEC: 26 Apr 2024, 16:49
Role: Director
Next action: Open filing details

4 COO

COOPER COMPANIES, INC.

Report period: 01 Apr 2024
Transactions: 3
Transaction value: $0
Accepted by SEC: 03 Apr 2024, 17:53
Role: Director
Next action: Open filing details

4

Inari Medical, Inc.

Report period: 18 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 May 2023, 18:16
Role: Director
Next action: Open filing details

4 COO

COOPER COMPANIES, INC.

Report period: 01 Apr 2023
Transactions: 3
Transaction value: $0
Accepted by SEC: 03 Apr 2023, 18:25
Role: Director
Next action: Open filing details

4

HANGER, INC.

Report period: 03 Oct 2022
Transactions: 1
Transaction value: -$1,272,206
Accepted by SEC: 04 Oct 2022, 17:19
Role: Director
Next action: Open filing details

4 COO

COOPER COMPANIES, INC.

Report period: 01 Oct 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Oct 2022, 16:09
Role: Director
Next action: Open filing details

3 COO

COOPER COMPANIES, INC.

Report period: 01 Oct 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 04 Oct 2022, 16:06
Role: Director
Next action: Open filing details

4

HANGER, INC.

Report period: 02 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Jun 2022, 16:48
Role: Director
Next action: Open filing details

4

Inari Medical, Inc.

Report period: 26 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 27 May 2022, 16:38
Role: Director
Next action: Open filing details

4

Intersect ENT, Inc.

Report period: 13 May 2022
Transactions: 14
Transaction value: -$3,296,182
Accepted by SEC: 16 May 2022, 18:35
Role: Director
Next action: Open filing details

4

Intersect ENT, Inc.

Report period: 03 Jun 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 07 Jun 2021, 21:11
Role: Director
Next action: Open filing details

4

Inari Medical, Inc.

Report period: 27 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 May 2021, 18:37
Role: Director
Next action: Open filing details

4

HANGER, INC.

Report period: 26 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 27 May 2021, 17:14
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .